Anticoagulation Myth Busters


“My newly diagnosed AF patient is already on a NOAC for thromboprophylaxis following joint replacement, they are therefore also adequately anticoagulated for their AF”


“Care should be taken when prescribing NOACs, as the doses used for indications such as joint replacement, acute coronary syndromes/stable coronary artery disease, venous thromboembolism and AF vary. Patients post-hip and knee replacement will be on a lower dose than required for the prevention of AF-related stroke hence, in this circumstance, the dose will need to be increased, please consult individual summary of product characteristics.”1-4

This site is intended for Healthcare Professionals only

If you are not a healthcare professional, please Click Here